Debbie Cohen
Professor of Medicine at the Hospital of the University of Pennsylvania
Director, Neuroendocrine Tumor Translational Center of Excellence (NET TCE) , Hospital of the University Of Pennsylvania
Director of Clinical Research Renal Division, University of Pennsylvania
Department: Medicine
Contact information
One Founders Pavilion
3400 Spruce Street
Philadelphia, PA 19104
3400 Spruce Street
Philadelphia, PA 19104
Office: 2156627544
Email:
debbie.cohen@uphs.upenn.edu
debbie.cohen@uphs.upenn.edu
Links
Penn Kidney Medicine Comprehensive Hypertension Center (ASH-certified)
Penn's Renal-Electrolyte and Hypertension Division
Renal-Electrolyte and Hypertension Clinical Trials--Hypertension/SPYRAL HTN-OFF MED and SPYRAL HTN-ON MED
Renal-Electrolyte and Hypertension Research Interests--Nephrology Clinical Research
Penn Kidney Medicine Dialysis Care
Penn Medicine’s Neuroendocrine Tumor Program
Penn Kidney Medicine Comprehensive Hypertension Center (ASH-certified)
Penn's Renal-Electrolyte and Hypertension Division
Renal-Electrolyte and Hypertension Clinical Trials--Hypertension/SPYRAL HTN-OFF MED and SPYRAL HTN-ON MED
Renal-Electrolyte and Hypertension Research Interests--Nephrology Clinical Research
Penn Kidney Medicine Dialysis Care
Penn Medicine’s Neuroendocrine Tumor Program
Education:
MBBCH ( )
University of Witwatersrand, Johannesburg, South Africa, 1990.
MBBCH ( )
University of Witwatersrand, Johannesburg, South Africa, 1990.
Post-Graduate Training
Medicine & Surgery Internship, Hillbrow General Hospital, South Africa, 1991-1991.
Intern in Medicine, Albert Einstein Medical Center, Philadelphia, PA, 1995-1996.
Residency, Internal Medicine, Albert Einstein Medical Center, 1996-1998.
Fellow, Nephrology, Hospital of the University of Pennsylvania, 1998-2000.
Permanent linkMedicine & Surgery Internship, Hillbrow General Hospital, South Africa, 1991-1991.
Intern in Medicine, Albert Einstein Medical Center, Philadelphia, PA, 1995-1996.
Residency, Internal Medicine, Albert Einstein Medical Center, 1996-1998.
Fellow, Nephrology, Hospital of the University of Pennsylvania, 1998-2000.
Description of Research Expertise
complex hypertension, adrenal hypertension, pheochromocytoma, chronic kidney diseaseDescription of Itmat Expertise
Dr. Cohen has a research interest in the effects of different antihypertensive medications on pulse wave velocity in patients with proteinuric kidney disease.Selected Publications
Bancos I, Atkinson E, Eng C, Young WF Jr, Neumann HPH; International Pheochromocytoma and Pregnancy Study Group.: Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature. Lancet Diabetes Endocrinol. 9(1): 13-21, January 2021.Greenberg SE, Jacobs MF, Wachtel H, Anson A, Buchmann L, Cohen DL, Bonanni M, Bennett B, Naumer A, Schaefer AM, Kohlmann W, Nathanson KL, Else T, Fishbein L.: Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome. Genet Med 22(12): 2101-2107, December 2020.
Wachtel H, Hutchens T, Baraban E, Schwartz LE, Montone K, Baloch Z, LiVolsi V, Krumeich L, Fraker DL, Nathanson KL, Cohen DL, Fishbein L.: Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems. J Clin Endocrinol Metab 105(12): e4661-4670, December 2020.
Malhotra R, Katz R, Jotwani V, Agarwal A, Cohen DL, Cushman WC, Ishani A, Killeen AA, Kitzman DW, Oparil S, Papademetriou V, Parikh CR, Raphael KL, Rocco MV, Tamariz LJ, Whelton PK, Wright JT Jr, Shlipak MG, Ix JH. : Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial). Am J Kidney Dis. S0272-6386(20): 31142-2, December 2020.
Grams ME, Surapaneni A, Appel LJ, Lash JP, Hsu J, Diamantidis CJ, Rosas SE, Fink JC, Scialla JJ, Sondheimer J, Hsu CY, Cheung AK, Jaar BG, Navaneethan S, Cohen DL, Schrauben S, Xie D, Rao P, Feldman HI; CRIC study investigators. : Clinical events and patient-reported outcome measures during CKD progression: findings from the CRIC study. Nephrol Dial Transplant. 2 December 2020.
Cohen JB, Denker MG, Cohen DL, Townsend RR.: Cardiovascular Events and Mortality in White Coat Hypertension. Ann Intern Med. 2 8171(8): 603-604, October 2020.
Ishigami J, Taliercio JT, Feldman HI, Srivastava A, Townsend RR, Cohen DL, Horwitz EJ, Rao P, Charleston J, Fink JC, Ricardo AC, Sondheimer J, Chen TK, Wolf M, Isakova T, Appel LJ, Matsushita K; CRIC study Investigators.: Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 31(8): 1836-1846, August 2020.
Chang AR, Kramer H, Wei G, Boucher R, Grams ME, Berlowitz D, Bhatt U, Cohen DL, Drawz P, Punzi H, Freedman BI, Haley W, Hawfield A, Horwitz E, McLouth C, Morisky D, Papademetriou V, Rocco MV, Wall B, Weiner DE, Zias A, Beddhu S; SPRINT Research Group.: Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT. Clin J Am Soc Nephrol August 2020.
Böhm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Konstantinidis D, Choi JW, East C, Lee DP, Ma A, Ewen S, Cohen DL, Wilensky R, Devireddy CM, Lea J, Schmid A, Weil J, Agdirlioglu T, Reedus D, Jefferson BK, Reyes D, D'Souza R, Sharp ASP, Sharif F, Fahy M, DeBruin V, Cohen SA, Brar S, Townsend RR; SPYRAL HTN-OFF MED Pivotal Investigators.: Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet 2(395): 1444-1451, May 2020.
Ghazi L, Yaffe K, Tamura MK, Rahman M, Hsu CY, Anderson AH, Cohen JB, Fischer MJ, Miller ER 3rd, Navaneethan SD, He J, Weir MR, Townsend RR, Cohen DL, Feldman HI, Drawz PE; CRIC Study Investigators.: Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD. Clin J Am Soc Nephrol 15(4): 455-464, April 2020.